Raymond James & Associates’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-3,330
| Closed | -$21K | – | 3690 |
|
2019
Q4 | $21K | Sell |
3,330
-100
| -3% | -$631 | ﹤0.01% | 3524 |
|
2019
Q3 | $29K | Buy |
3,430
+2,000
| +140% | +$16.9K | ﹤0.01% | 3451 |
|
2019
Q2 | $10K | Buy |
1,430
+150
| +12% | +$1.05K | ﹤0.01% | 3492 |
|
2019
Q1 | $10K | Sell |
1,280
-150
| -10% | -$1.17K | ﹤0.01% | 3474 |
|
2018
Q4 | $23K | Buy |
1,430
+410
| +40% | +$6.59K | ﹤0.01% | 3383 |
|
2018
Q3 | $34K | Buy |
+1,020
| New | +$34K | ﹤0.01% | 3454 |
|